| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Efficacy and safety of emtricitabine vs stavudine in combination therapy in antiretroviral-naive patients: a randomized trial. | JAMA | 2004 | 1.42 |
| 2 | Prospective randomized trial of emtricitabine versus lamivudine short-term monotherapy in human immunodeficiency virus-infected patients. | J Infect Dis | 2003 | 1.41 |
| 3 | A randomized study of emtricitabine and lamivudine in stably suppressed patients with HIV. | AIDS | 2004 | 1.14 |
| 4 | Baseline genotype as a predictor of virological failure to emtricitabine or stavudine in combination with didanosine and efavirenz. | AIDS Res Hum Retroviruses | 2007 | 0.98 |
| 5 | Comparative efficacy of nucleoside/nucleotide reverse transcriptase inhibitors in combination with efavirenz: results of a systematic overview. | HIV Clin Trials | 2007 | 0.97 |